Immatics (IMTX) Change in Accured Expenses (2019 - 2022)
Immatics' (IMTX) quarterly Change in Accured Expenses came in at -$12.3 million in Q3 2022, down 263.15% year-on-year from $7.5 million in Q3 2021, and down 117.65% quarter-over-quarter from $69.7 million in Q2 2022.
Immatics (IMTX) Change in Accured Expenses (2019 - 2022) Analysis & Trends
Immatics has disclosed Change in Accured Expenses across 4 years of filings, most recently posting -$12.3 million for Q3 2022.
- Change in Accured Expenses for Q3 2022 came in at -$12.3 million, down 263.15% year-over-year; the trailing twelve-month figure through Sep 2022 was $74.1 million (up 386.56% YoY), and the FY2021 annual result was -$36.4 million, down 30.4% from the prior year.
- Change in Accured Expenses came in at -$12.3 million for Q3 2022 at Immatics, down from $69.7 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $69.7 million in Q2 2022 to a low of -$20.1 million in Q4 2021.
- The 4-year median for Change in Accured Expenses is -$5.7 million (2021), against an average of $10.5 million.
- Peak annual rise in Change in Accured Expenses reached 1325.95% in 2022, while the deepest fall reached 263.15% in 2022.
- Immatics' Change in Accured Expenses stood at $46.7 million in 2019, then slumped by 118.79% to -$8.8 million in 2020, then tumbled by 128.77% to -$20.1 million in 2021, then surged by 38.78% to -$12.3 million in 2022.
- The last three Change in Accured Expenses figures came in at -$12.3 million (Q3 2022), $69.7 million (Q2 2022), and $36.8 million (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -12.29 Mn |
| Sep 30, 2022 | -12.29 Mn |
| Jun 30, 2022 | 69.66 Mn |
| Jun 30, 2022 | 69.66 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Mar 31, 2022 | 36.81 Mn |
| Dec 31, 2021 | -20.08 Mn |
| Dec 31, 2021 | -20.08 Mn |
| Sep 30, 2021 | -3.38 Mn |
| Sep 30, 2021 | -3.38 Mn |
| Jun 30, 2021 | -5.68 Mn |
| Jun 30, 2021 | -5.68 Mn |
| Mar 31, 2021 | -8.02 Mn |
| Mar 31, 2021 | -8.02 Mn |
| Dec 31, 2020 | -8.78 Mn |
| Dec 31, 2020 | -8.78 Mn |
| Dec 31, 2019 | 46.71 Mn |
| Dec 31, 2019 | 46.71 Mn |